What will be the next major FDA decision on psychedelic therapies? | Categorical | | | 7 months ago | |
Will FDA approve MDMA for PTSD treatment by mid-August? | Binary | | | 7 months ago | |
Will Lykos Therapeutics submit revised clinical trial data by end of 2024? | Binary | | | 7 months ago | |
Will FDA panel reconsider MDMA for PTSD treatment by mid-2025? | Binary | | | 7 months ago | |
What will Lykos Therapeutics do next for MDMA? | Categorical | | | 7 months ago | |
Will FDA approve MDMA-assisted therapy for PTSD by August 31, 2025? | Binary | | | 5 months ago | |
What will be the public opinion on MDMA for PTSD treatment by end of 2024? | Categorical | | | 7 months ago | |
What will be the outcome of the additional Phase 3 study for MDMA-assisted therapy for PTSD by March 31, 2025? | Categorical | | | 5 months ago | |
What will be the FDA's decision on MDMA-assisted therapy for PTSD by August 31, 2025? | Categorical | | | 5 months ago | |
Will Lykos Therapeutics complete the additional Phase 3 study for MDMA-assisted therapy for PTSD by December 31, 2024? | Binary | | | 5 months ago | |
How will Lykos Therapeutics' stock price react within 1 week after FDA decision on MDMA-assisted therapy for PTSD? | Categorical | | | 5 months ago | |
Will positive results from the additional Phase 3 study for MDMA-assisted therapy for PTSD be published by March 31, 2025? | Binary | | | 5 months ago | |
